-
NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)
(PAR-19-137)
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): February 6, 2019; June 6, 2019; October 4, 2019; February 6, 2020; June 8, 2020; October 6, 2020; February 8, 2021; June 6, 2021; October 6, 2021), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
ImmuneChip: Engineering Microphysiological Immune Tissue Platforms (U01 Clinical Trial Not Allowed)
(PAR-19-138)
National Institute of Biomedical Imaging and Bioengineering
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
Application Receipt Date(s): February 27, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Independent Basic Experimental Studies with Humans Required)
(PAR-19-141)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Independent Basic Experimental Studies with Humans Required)
(PAR-19-142)
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): February 15, 2019; June 18, 2019; October 17, 2019; February 13, 2020; June 18, 2020; and October 15, 2020,, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NIDCD Research Career Enhancement Award for Established Investigators (K18 Basic Experimental Studies with Humans Required)
(PAR-19-143)
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): February 8, 2019; June 6, 2019; October 8, 2019; February 6, 2020; June 8, 2020; and October 8, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed)
(PAR-19-144)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes (R01 Clinical Trial Optional)
(RFA-AT-19-008)
National Center for Complementary and Integrative Health
Application Receipt Date(s): March 15, 2019), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes (R21 Clinical Trial Optional)
(RFA-AT-19-009)
National Center for Complementary and Integrative Health
Application Receipt Date(s): March 15, 2019), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
U.S.-China Program for Biomedical Collaborative Research (R01 Clinical Trial Optional)
(RFA-CA-19-009)
National Cancer Institute
National Institute of Environmental Health Sciences
National Eye Institute
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): February 21, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R41/R42 - Clinical Trial Not Allowed)
(RFA-DA-19-030)
National Institute on Drug Abuse
Application Receipt Date(s): March 4, 2019, by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R43/R44 - Clinical Trial Not Allowed)
(RFA-DA-19-031)
National Institute on Drug Abuse
Application Receipt Date(s): March 4, 2019, by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Resources for Technology Dissemination (U24 Clinical Trial Not Allowed)
(RFA-EB-18-002)
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): February 27, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.